Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Microglia mediate postoperative hippocampal inflammation and cognitive decline in mice
Xiaomei Feng, Martin Valdearcos, Yosuke Uchida, David Lutrin, Mervyn Maze, Suneil K. Koliwad
Xiaomei Feng, Martin Valdearcos, Yosuke Uchida, David Lutrin, Mervyn Maze, Suneil K. Koliwad
View: Text | PDF
Research Article Inflammation Neuroscience

Microglia mediate postoperative hippocampal inflammation and cognitive decline in mice

  • Text
  • PDF
Abstract

Surgery can induce cognitive decline, a risk that increases with advancing age. In rodents, postoperative cognitive decline (POCD) is associated with the inflammatory activation of hippocampal microglia. To examine the role of microglia in POCD, we inhibited the colony-stimulating factor 1 receptor (CSF1R) in adult mice, effectively depleting CNS microglia. Surgical trauma (tibial fracture) reduced the ability of mice to remember a conditioned response learned preoperatively, a deficit more pronounced and persistent in mice with diet-induced obesity (DIO). Whereas microglial depletion by itself did not affect learning or memory, perioperative microglial depletion remarkably protected mice, including those with DIO, from POCD. This protection was associated with reduced hippocampal levels of inflammatory mediators, abrogation of hippocampal recruitment of CCR2+ leukocytes, and higher levels of circulating inflammation-resolving factors. Targeting microglia may thus be a viable strategy to mitigate the development of POCD, particularly in those with increased vulnerability.

Authors

Xiaomei Feng, Martin Valdearcos, Yosuke Uchida, David Lutrin, Mervyn Maze, Suneil K. Koliwad

×

Figure 3

Perioperative PLX5622 treatment prevents surgery-induced entry of CCR1-expressing cells into the hippocampal region of the brain in mice.

Options: View larger image (or click on image) Download as PowerPoint
Perioperative PLX5622 treatment prevents surgery-induced entry of CCR1-e...
(A) Representative immunofluorescence images of hippocampal sections from CCR2RFP/+: Cx3CR1GFP/+ mice (n = 4, 3 sections per sample), showing that sham-treated mice do not have CCR2-expressing (RFP+) cells in the hippocampus or associated choroid plexus. (B) Similar images in mice 24 hours after surgery, showing that depletion of microglia (green) by perioperative PLX5622 treatment is associated with the complete disappearance of CCR2-expressing cells otherwise present in the choroid plexus and entering the hippocampus at this time point. Scale bars: 50 mm. (C) Quantification of the prevention of surgically induced CCR2RFP/+ cell infiltration by PLX5622 treatment in mice from B (n = 8 mice/group; *P < 0.05 vs. control by two-tailed Student’s t test). (D) FACS data from blood samples taken from control and PLX5622-treated mice 3 days following surgery, showing no effect of perioperative PLX5622 treatment on the number of circulating CCR2RFP/+ cells (n = 8 mice/group; analyzed by two-tailed Student’s t test).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts